Wall St. Cheat Sheet

Wall St. Cheat Sheet » Trading »

Haemonetics Reiterated at Outperform With $88 Target and 1 Stock Analysis to Track

By Leah Powell | More Articles

October 31, 2012

Haemonetics Corp. (NYSE:HAE) base business is believed by Barrington to continue to be strong as its integration of PALL is proceeding better than predicted. The firm increased its target on the stock to $88 from $79 yesterday, and it keeps Outperform rating on the stock.

CapitalSource Inc. (NYSE:CSE) has reported Q3 EPS 14c, consensus 13c.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

More Articles About: Business Haemonetics Corp. Investing Markets NYSE:CSE NYSE:HAE Stocks Trading

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet^®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Wall St. Cheat Sheet has been featured in these fine media outlets:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business